Physician profile
Daniel Cooley
NPI 1356904437
$1,975.51
in general payments reported to CMS, 2019-2025
27 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $445 · 2023: $80.20 · 2024: $244 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $328.41 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $290.29 | 2022-2025 | |
| Glaxosmithkline, LLC. | $256.63 | 2022-2025 | Shingrix |
| Pfizer INC. | $142.95 | 2025 | |
| Novo Nordisk INC | $133.38 | 2022-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $79.57 | 2024-2025 | |
| Corcept Therapeutics | $76.47 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $76.27 | 2025 | Inspire |
| Axsome Therapeutics, INC. | $74.25 | 2025 | Auvelity |
| Myriad Women'S Health, INC. | $58.57 | 2023 | Myrisk |
| Exact Sciences Corporation | $41.05 | 2024-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $38.63 | 2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.76 | 2025 | Jardiance |
| Astellas Pharma US INC | $37.23 | 2025 | Veozah |
| Dexcom, INC. | $36.55 | 2023-2025 | Dexcom G6 Transmitter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $36.21 | 2025 | Voquezna |
| Lilly USA, LLC | $31.16 | 2025 | Jardiance, Mounjaro, Zepbound |
| Stryker Corporation | $28.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $24.35 | 2025 | Proclaim |
| Boston Scientific Corporation | $23.51 | 2025 | Watchman Flx |
| Seqirus USA INC | $21.51 | 2025 | Fluad, Flucelvax |
| Bayer Healthcare Pharmaceuticals INC. | $18.44 | 2025 | |
| Globus Medical, INC. | $18.07 | 2025 | Senza |
| Sanofi Pasteur INC. | $17.88 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.78 | 2024 | Zoryve |
| Tolmar, INC. | $15.84 | 2025 | Jatenzo |
| Medtronic, INC. | $15.42 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.